Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma
1 other identifier
interventional
191
1 country
2
Brief Summary
Group treatments may be helpful for Veterans who have experienced military sexual trauma (MST). By doing this study, the investigators hope to learn if two different groups: Warrior Renew and Health \& Wellness are effective in reducing mental health symptoms in Veterans who have experienced MST and if either is more effective than the other. Participation in this research will last about 16 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2023
CompletedFirst Posted
Study publicly available on registry
March 20, 2023
CompletedStudy Start
First participant enrolled
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
ExpectedAugust 11, 2025
August 1, 2025
2 years
February 23, 2023
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD Checklist for DSM-5 (PCL-5)
The 20-item PCL-550 will be used to assess symptoms of PTSD using items consistent with the Diagnostic and Statistical Manual 5 (DSM-5, 2013) criteria for PTSD. The wording of PCL-5 items reflects both changes to existing symptoms and the addition of new symptoms in DSM-5. The PCL-5 uses a self-report Likert rating scale of 0-4 for each symptom, including the anchors of: "Not at all," "A little bit," "Moderately," "Quite a bit," and "Extremely." A score of 31-33 has been identified as the optimally efficient cutoff for a probable diagnosis of PTSD (VA National Center for PTSD, 2015).
Changes from baseline to end of 8-week treatment.
Secondary Outcomes (9)
Patient Health Questionnaire - 9 (PHQ-9)
Changes from baseline to after 8-week treatment and at end of 16-week follow up.
Generalized Anxiety Disorder Assessment (GAD-7)
Changes from baseline to after 8-week treatment and at end of 16-week follow up.
Dimensions of Anger Reactions-5 (DAR-5)
Changes from baseline to after 8-week treatment and at end of 16-week follow up.
Internalized Shame Scale (ISS)
Changes from baseline to after 8-week treatment and at end of 16-week follow up.
Posttraumatic Cognitions Inventory (PTCI)
Changes from baseline to after 8-week treatment and at end of 16-week follow up.
- +4 more secondary outcomes
Study Arms (2)
Health & Wellness
ACTIVE COMPARATOR8 weeks, once weekly 90 minute sessions, groups of 8-10 subjects, gender stratified
Warrior Renew
EXPERIMENTAL8 weeks, once weekly 90 minute sessions, groups of 8-10 subjects, gender stratified
Interventions
PowerPoint slide decks will be shown via shared screen. The wellness group will be largely educational in nature and will encourage discussion, setting goals, and making healthy choices. Similar topics covered in this group have been used previously in health promotion classes.
The group format includes warm-up community building exercises, psychoeducational presentation of material standardized by the use of PowerPoint slides, followed by discussion of the information and interactive exercises, and closes with exercises to improve affect management skills, such as mindfulness or guided imagery.
Eligibility Criteria
You may qualify if:
- Has established care with VA medical or mental health provider.
- Reports having experienced military sexual trauma.
- Between the ages of 18 and 75.
- Is an outpatient and is able to comply with all study procedures, including the eight weeks of group treatment and the assessment measures.
- Positive screen on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5).
- Able to participate in virtual group therapy via telehealth.
You may not qualify if:
- Impaired decision-making capacity that in the clinical judgment of their provider would affect their ability to provide informed consent.
- Current/active suicidal ideation as evidenced by a positive screen on the Columbia Suicide Severity Rating Scale (C-SSRS), or a suicide attempt or psychiatric hospitalization within the past year.
- Dissociative, delusional or psychotic symptoms due to medical conditions or mental health disorders that in the clinical judgement of the PI or LSI would impede the participant's ability to participate actively in the study.
- Current/active diagnosis of a substance use disorder or an alcohol use disorder as measured by the Alcohol Use Disorders Identification Test-Concise (AUDIT-C).
- Unable to read English.
- Currently receiving trauma-focused group or individual psychotherapy treatment. (Previous psychotherapy, current pharmacotherapy, peer support groups, or maintenance therapy groups or individual therapy, defined as therapeutic services that have been ongoing for at least three months and are not trauma-focused, is acceptable).
- Concurrently enrolled in another research protocol involving a mental health intervention during this study.
- Has had previous Warrior Renew treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Portland Health Care System
Portland, Oregon, 97239, United States
VA Puget Sound Health Care System
Seattle, Washington, 98105, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amanda E Wood, PhD
VA Puget Sound Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Study participants will be informed that they will be randomized to one of two groups but will not be informed which group is expected to perform better.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Research Psychologist
Study Record Dates
First Submitted
February 23, 2023
First Posted
March 20, 2023
Study Start
July 17, 2023
Primary Completion
July 30, 2025
Study Completion (Estimated)
October 30, 2026
Last Updated
August 11, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
As per our current IRB restrictions, no individual participant data will be available to outside researchers.